Realtime | Geld | Brief | Zeit |
---|---|---|---|
0,022 | 0,034 | 12:46 |
Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
10.04. | XFRA 61N1: AUSSETZUNG/SUSPENSION | 129 | Xetra Newsboard | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILSTAGEZERO LIFE SCIENC.... ► Artikel lesen | |
05.04. | Stagezero Life Sciences Ltd (2): Stagezero Life's application to OSC for MCTO denied | 4 | Stockwatch | ||
05.04. | StageZero Life Sciences Ltd: StageZero Life Sciences Provides an Update on Application for Management Cease Trade Order | 346 | ACCESSWIRE | TORONTO, ON / ACCESSWIRE / April 5, 2024 / StageZero Life Sciences, Ltd. (TSX:SZLS)(OTCQB:SZLSF) ("StageZero" or the "Company"), an integrated healthcare company with the first and only mRNA multi-cancer... ► Artikel lesen | |
03.04. | Stagezero Life Sciences Ltd (2): Stagezero delays 2023 results filing until May 31 | 1 | Stockwatch | ||
03.04. | StageZero Life Sciences Ltd: StageZero Life Sciences Announces Delay to Fourth Quarter and Year End 2023 Financial Results | 250 | ACCESSWIRE | TORONTO, ON / ACCESSWIRE / April 2, 2024 / StageZero Life Sciences, Ltd. (TSX:SZLS)(OTCQB:SZLSF) ("StageZero" or the "Company"), an integrated healthcare company with the first and only mRNA multi-cancer... ► Artikel lesen | |
29.11.23 | Stagezero Life Sciences Ltd (2): Stagezero Life warrants to expire Dec. 4 | 3 | Stockwatch | ||
15.11.23 | Stagezero Life Sciences GAAP EPS of -$0.01, revenue of $0.75M | 2 | Seeking Alpha | ||
15.11.23 | Stagezero Life Sciences Ltd (2): Stagezero Life Sciences loses $3-million in nine months | 1 | Stockwatch | ||
15.11.23 | StageZero Life Sciences Ltd: StageZero Life Sciences, Ltd Announces Q3 2023 Financial Results and Operational Update | 298 | ACCESSWIRE | TORONTO, ON / ACCESSWIRE / November 15, 2023 / StageZero Life Sciences ("StageZero" or the "Company") (TSX:SZLS), an integrated healthcare company with the first and only mRNA multi-cancer diagnostic... ► Artikel lesen | |
14.11.23 | StageZero Life Sciences and My One Medical Source collaborate | 1 | The Market Herald Canada | ||
14.11.23 | StageZero Life Sciences Ltd: StageZero Life Sciences Partners with My One Medical Source and 1,000+ Medical Access Points in the USA | 402 | ACCESSWIRE | Aristotle and AVRT to be offered to My One Medical Source's Customer BaseTORONTO, ON / ACCESSWIRE / November 14, 2023 / StageZero Life Sciences, Ltd. (TSX:SZLS)(OTCQB:SZLSF) ("StageZero" or the "Company")... ► Artikel lesen | |
07.11.23 | Stagezero Life Sciences Ltd (2): Stagezero to offer mental support for cancer patients | 1 | Stockwatch | ||
07.11.23 | StageZero Life Sciences Ltd: StageZero Life Sciences' Clinical Business Introduces Fourth Pillar to Cancer Offerings | 212 | ACCESSWIRE | Care Oncology Partners with WellnessScript to Offer Mental Health support to cancer patientsTORONTO, ON / ACCESSWIRE / November 7, 2023 / StageZero Life Sciences, Ltd. (TSX:SZLS)(OTCQB:SZLSF) ("StageZero"... ► Artikel lesen | |
20.10.23 | StageZero Life Sciences Ltd: StageZero Life Sciences' Clinical Business Introduces Third Pillar to Cancer Offerings | 480 | ACCESSWIRE | CareOncology partners with The Source Functional Nutrition to offer nutritional guidance to cancer patients.TORONTO, ON / ACCESSWIRE / October 20, 2023 / StageZero Life Sciences, Ltd. (TSX:SZLS)(OTCQB:SZLSF)... ► Artikel lesen | |
20.06.23 | StageZero Life Sciences Ltd.: StageZero Life Sciences, Ltd. Announces Temporary Repricing of Warrants Expiring in 2023 and 2024 | 368 | Newsfile | Toronto, Ontario--(Newsfile Corp. - June 20, 2023) - StageZero Life Sciences, Ltd. (TSX: SZLS) (OTCQB: SZLSF) ("StageZero" or the "Company"), a vertically integrated healthcare company devoted to improving... ► Artikel lesen | |
08.06.23 | StageZero Life Sciences Ltd.: StageZero Life Sciences, Ltd Announces Results of Resolutions at Annual and Special Meeting | 469 | Newsfile | Toronto, Ontario--(Newsfile Corp. - June 7, 2023) - StageZero Life Sciences, Ltd (TSX: SZLS) (OTCQB: SZLSF) ("StageZero" or the "Company") is pleased to report that shareholders voted in favour of... ► Artikel lesen | |
05.06.23 | StageZero Life Sciences Ltd.: StageZero Life Sciences, Ltd. Special and Annual General Meeting Conference Call | 487 | Newsfile | Toronto, Ontario--(Newsfile Corp. - June 5, 2023) - StageZero Life Sciences, Ltd. (TSX: SZLS) ("StageZero" or the "Company") today announced that it will host a conference call as part of its Special... ► Artikel lesen | |
16.05.23 | StageZero Life Sciences Ltd.: StageZero Life Sciences, Ltd Announces Q1 2023 Financial Results - 15.2% Growth in Revenue over Q4 2022 - and Operational Update | 265 | Newsfile | Toronto, Ontario--(Newsfile Corp. - May 16, 2023) - StageZero Life Sciences (TSX: SZLS) ("StageZero" or the "Company"), a vertically-integrated healthcare company devoted to improving the early detection... ► Artikel lesen | |
15.05.23 | StageZero Life Sciences Ltd.: StageZero to Issue Q1 2023 Financial Results After Market Closes May 15, 2023 | 336 | Newsfile | Toronto, Ontario--(Newsfile Corp. - May 15, 2023) - StageZero Life Sciences (TSX: SZLS) ("StageZero" or the "Company") today announced that it will release its first quarter 2023 operational results... ► Artikel lesen |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
CARL ZEISS MEDITEC | 99,85 | -0,55 % | JPMORGAN stuft CARL ZEISS MEDITEC AG auf 'Underweight' | NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat die Einstufung für Carl Zeiss Meditec vor Zahlen für das zweite Geschäftsquartal auf "Underweight" mit einem Kursziel von 70 Euro belassen. Seine... ► Artikel lesen | |
INTUITIVE SURGICAL | 351,60 | +0,33 % | Quartalszahlen: China sei Dank: Intuitive Surgical übertrifft Erwartungen, Aktie steigt! | © Foto: Frank Molter - picture allianceDie Aktie des Herstellers von Medizinrobotern Intuitive Surgical ist nach guten Quartalszahlen gefragt und steigt.Erholung in China ließ lange auf sich warten... ► Artikel lesen | |
PLUS THERAPEUTICS | 1,592 | +5,15 % | Micro-Cap Brain Cancer Focused Plus Therapeutics Poised To Receive $3M From US Department of Defense | ||
BOSTON SCIENTIFIC | 68,00 | -0,73 % | ROUNDUP: Boston Scientific Boosts FY24 Outlook | WASHINGTON (dpa-AFX) - While reporting financial results for the first quarter on Wednesday, medical devices company Boston Scientific Corp. (BSX) raised its adjusted earnings and net sales... ► Artikel lesen | |
MOUNTAIN VALLEY MD | 0,041 | -4,21 % | Mountain Valley MD Holdings Inc: Mountain Valley licenses Agrarius plant signalling tech | ||
ASENSUS SURGICAL | 0,223 | -1,68 % | Asensus Surgical, Inc. Announces Non-Binding Acquisition Proposal and Exclusivity Arrangement with KARL STORZ SE & Co. KG | RESEARCH TRIANGLE PARK, N.C., April 03, 2024 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC) ("Asensus" or the "Company"), a medical device company that is digitizing the interface... ► Artikel lesen | |
INVIVO THERAPEUTICS HOLDINGS | 0,302 | 0,00 % | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 23.02.2024 | The following instruments on Boerse Frankfurt do have their last trading day on 23.02.2024.Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 23.02.2024.ISIN NameCA58503M4083 MEDIVOLVE... ► Artikel lesen | |
MEDIVOLVE | 0,003 | 0,00 % | Medivolve Inc (2): Medivolve changes auditor to MS Partners | ||
REWALK ROBOTICS | 4,675 | 0,00 % | ReWalk Robotics Ltd. - 8-K, Current Report | ||
SENSEONICS | 0,386 | -4,40 % | Senseonics Holdings, Inc. Announces Data From the Eversense Post Approval Study to Be Presented at the 17th International Conference on Advanced Technologies and Treatments for Diabetes | Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for... ► Artikel lesen | |
EKSO BIONICS | 1,055 | -6,22 % | Ekso Bionics Holdings, Inc.: Ekso Bionics to Report First Quarter 2024 Financial Results on April 29, 2024 | ||
BIOCEPT | 6,800 | 0,00 % | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 02.11.2023 | The following instruments on Boerse Frankfurt do have their last trading day on 02.11.2023Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 02.11.2023ISIN NameCA91834N1006 VSBLTY... ► Artikel lesen | |
IMUNON | 1,250 | +2,46 % | Imunon, Inc.: IMUNON's IND Application Cleared to Begin Human Testing of IMNN-101 | Company expects enrollment in Phase 1 proof-of-concept study of DNA-based vaccine technology to begin in the second quarter LAWRENCEVILLE, N.J., April 18, 2024 (GLOBE NEWSWIRE) -- IMUNON, Inc. (NASDAQ:... ► Artikel lesen | |
AVINGER | 2,750 | -100,00 % | Avinger, Inc.: Avinger Reports Fourth Quarter and Full Year 2023 Results | New Strategic Partnership Provides Funding to Support U.S. Growth Initiatives and Coronary Product Development, Opens New Pathway for Sales in AsiaREDWOOD CITY, CA / ACCESSWIRE / March 20, 2024 / Avinger... ► Artikel lesen | |
ROCKWELL MEDICAL | 1,446 | +5,24 % | Rockwell Medical Achieves Profitability on an Adjusted EBITDA Basis in the Fourth Quarter 2023 and Record Net Sales, Gross Profit and Gross Margin for the Full-Year 2023 | WIXOM, Mich.--(BUSINESS WIRE)--Rockwell Medical, Inc. (the "Company") (Nasdaq: RMTI), a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis... ► Artikel lesen |